INDEX PHARMACEUTICALS HOLDING AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.368 SEK | +5.14% |
|
+11.85% | +43.75% |
| Apr. 26 | InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 05 | Index Pharmaceuticals Holding AB Announces Board Resignations | CI |
Chart calendar InDex Pharmaceuticals Holding AB
d10fe91ba2a3d53b0faafb9e55.eZ9Ehwz3eyyu7Tln2SLFedjm-AYRigO9J34lYjzwFv0.LfMu0nafGn_jrFMhnWaGHYLUvHFf2m_3QQ5NDg2VfZw4-AD_X8IsGJirCQ~13a0f68b51def8008b3e45d35f58bbdc
Upcoming events on InDex Pharmaceuticals Holding AB
Past events on InDex Pharmaceuticals Holding AB
| 2024-02-27 | Investor Update Webinar |
| 2024-02-20 | Q4 2023 Earnings Release |
| 2023-11-27 | Q3 2023 Earnings Release |
| 2023-11-22 09:00 am | Business Update Call |
| 2023-10-15 04:30 am | United European Gastroenterology Week |
| 2023-10-02 | Redeye Autoimmune and Inflammatory Disease Conference |
| 2023-08-31 12:00 am | HC Andersen Capital Life Science Seminar |
| 2023-08-22 | Q2 2023 Earnings Release |
| 2023-06-01 09:00 am | Business Update Call - License Agreement |
| 2023-06-01 12:00 am | Redeye Growth Day |
| 2023-05-23 | Annual General Meeting |
| 2023-05-23 | Q1 2023 Earnings Release |
| 2023-05-09 07:00 am | Business Update Call |
| 2023-02-28 | European Crohn and Colitis Organisation Congress |
| 2023-02-22 | FY 2022 Earnings Release |
| 2022-11-22 | Q3 2022 Earnings Release |
| 2022-10-07 | United European Gastroenterology Conference |
| 2022-08-25 | Interim 2022 Earnings Release |
| 2022-06-01 11:00 am | Annual General Meeting |
| 2022-05-20 | Digestive Disease Week Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,09 0,00 - | 0,04 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 97,5 105 -7.14% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -86,8 -64,0 -35.58% | -56,2 -75,0 25.12% | -102 -98,1 -3.61% | -102 -176 42.1% | -106 -61,0 -74.02% | -257 |
|
EBIT Million SEK | Released Forecast Spread | -87,7 -64,0 -37.03% | -57,3 -76,0 24.54% | -103 -99,4 -3.56% | -103 -178 41.87% | -107 -63,0 -70.42% | -258 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -87,8 -64,0 -37.15% | 0,00 0,00 - | -103 -99,3 -3.75% | -100 -178 43.52% | -95,3 -49,0 -94.42% | -259 |
|
Net income Million SEK | Released Forecast Spread | -87,8 -64,0 -37.19% | 0,00 0,00 - | -103 -99,3 -3.75% | -100 -178 43.52% | -95,3 -172 44.46% | -259 |
|
EPS SEK | Released Forecast Spread | -1,19 -0,72 -65.28% | 0,00 0,00 - | -0,21 -0,32 34.38% | -0,19 -0,30 36.67% | -0,18 -0,32 43.75% | -0,49 |
| Announcement Date | 20/02/20 | 25/02/21 | 23/02/22 | 23/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 |
|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 |
|
Net income Million SEK | Released Forecast Spread | -37,9 |
|
EPS SEK | Released Forecast Spread | -0,07 |
| Announcement Date | 28/11/23 |
More events
Past sector events for InDex Pharmaceuticals Holding AB
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INDEX Stock
- Calendar InDex Pharmaceuticals Holding AB
